AKT1 and COVID-19: It is known that AKT phosphorylation is involved in thrombus formation through the PI3K/AKT signaling pathway that activates platelets, and the use of PI3K or AKT inhibitors potently abolishes the increased binding of platelet fibrinogen induced by incubation with patient sera with COVID-19 admitted to the ICU (24).